Moreover, research suggests TAM-EVs could influence lipid metabolism in cancer cells, shifting from a COX2/PGES pathway that promotes tumor growth to a COX1/TBXAS1 pathway, potentially curtailing the tumor-supporting effects of certain prostaglandins (9). This evidence concerns the gene PTGES and neoplasm.